What is a “written assurance” in the context of patent deposits?
A “written assurance” in the context of patent deposits is a statement provided by the applicant indicating that an acceptable deposit will be made. The MPEP 2411.03 mentions: “[I]n the event that an application for patent is otherwise in condition for allowance except for a required deposit and the Office has received a written assurance…
Read MoreHow does the USPTO handle requests for samples of biological materials?
The United States Patent and Trademark Office (USPTO) has specific procedures for handling requests for samples of biological materials. According to MPEP 2410: “The Office will not serve as a go-between for persons seeking samples from a depository.” Instead, the USPTO’s role is to: Provide certification to depositories that a request for a sample is…
Read MoreWhen should the deposit of biological material be made in relation to paying the issue fee?
It’s crucial to make the deposit of biological material well before paying the issue fee. The MPEP 2411.03 advises: “[A]pplicants need to make any necessary deposit of biological material well prior to payment of the issue fee such that the accession number is received with sufficient time remaining to amend the specification as required by…
Read MoreWhat happens if a patent application is in condition for allowance except for a required deposit?
If a patent application is in condition for allowance except for a required deposit, the USPTO may notify the applicant and set a three-month period for making the deposit. As stated in MPEP 2411.03: “[T]he Office may notify the applicant in a notice of allowability and set a three month period of time from the…
Read MoreHow does the USPTO handle enablement for microorganisms in patent applications?
The USPTO has specific guidelines for handling enablement issues related to microorganisms in patent applications. According to MPEP 2164.06(a): Patent applications involving living biological products, such as microorganisms, as critical elements in the process of making the invention, present a unique question with regard to availability. The MPEP cites the case of In re Argoudelis,…
Read MoreCan the three-month period for making a required deposit be extended?
No, the three-month period for making a required deposit cannot be extended. The MPEP 2411.03 clearly states: “This time period is not extendable under 37 CFR 1.136 (see 37 CFR 1.136(c)).” This means that applicants must ensure they can make the necessary deposit within the given three-month timeframe to avoid potential abandonment of their application.…
Read MoreWhat are the consequences of failing to make a required deposit within the specified time?
Failing to make a required deposit within the specified time can have serious consequences for a patent application. According to MPEP 2411.03: “Failure to make the needed deposit in accordance with this requirement will be considered a failure to prosecute the application under 35 U.S.C. 133 and result in abandonment of the application.” This means…
Read MoreWhat are the requirements for furnishing samples under the Budapest Treaty?
Under the Budapest Treaty, depositories are required to furnish samples of deposited biological materials under certain conditions. According to MPEP 2410: “For a depository to be recognized under the Budapest Treaty, it must be able to furnish samples of deposited biological material to authorized parties.” The specific requirements include: Providing samples to industrial property offices…
Read MoreHow should information about the deposit be added to the patent specification?
Information about the deposit must be added to the patent specification through a specific amendment process. The MPEP 2411.03 provides guidance: “Once the deposit has been made, information regarding the deposit, such as the name and address of the depository, the accession number and the date of the deposit, that is to be added to…
Read MoreWhat is an acceptable depository for biological materials in patent applications?
An acceptable depository for biological materials in patent applications can be either: An International Depositary Authority (IDA) established under the Budapest Treaty, or A depository recognized as suitable by the USPTO Commissioner As stated in MPEP 2405: “37 CFR 1.803 indicates that a depository will be recognized as acceptable for the purposes of these regulations…
Read More